Date/Time
Date(s) - 9 Oct 2012
5:30 PM - 7:30 PM
Location
Ventana Medical Systems, Inc.
at
Date: Tuesday, October 9, 2012
Time: 5:30 – 7:30 PM
Location: Ventana Medical Systems, a member of the Roche Group
1910 E.Innovation Park Drive, Tucson, AZ 85755
This event is open to the Public and Free to AZBio Members, Community Partners and Guests
Refreshments will be provided courtesy of Ventana Medical Systems
Registration is required. Please use the form below to register.
About Ventana
“Our commitment to cancer patients is global. Cancer knows no boundaries, and our resolve to fight it is limitless.”
Mara G. Aspinall
President, Ventana Medical Systems, Inc.
Head, Roche Tissue Diagnostics
Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.
Passionately pursuing their mission to improve the lives of all patients afflicted with cancer, the people of Ventana discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 200 cancer tests with related instruments right here in southern Arizona for 56 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety.
Linking the most accurate diagnosis with the most targeted and relevant therapeutic is the essence of Personalized Healthcare. Clearly, the value of the Personalized Healthcare approach is rooted in positive outcomes for the patient—saving lives and improving the quality of life. Ventana focuses on accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient biopsies at the molecular level to help determine the best course of therapy for each individual patient. As a member of the Roche Group, drawing on powerful partnerships with world-class scientific institutes, there is no company in the world in a better position to make this approach a reality.
Arizona Bioindustry Partner Organizations:
